Menu
Log in

35th Annual Fall Symposium Lecture Series (Virtual) Session 2, COVID-19 Testing Platforms, Challenges and Controversies.

Event
35th Annual Fall Symposium Lecture Series (Virtual) Session 2, COVID-19 Testing Platforms, Challenges and Controversies.
 
October 08, 2020 4:00 PM - 6:00 PM
 
Location: Virtual Symposium

Registered attendees (72)

Date Name
September 23, 2020 Sapico, Francisco L.
September 22, 2020
September 22, 2020
September 21, 2020 Anonymous user
September 19, 2020
September 17, 2020 Cabinian, Antonio
September 16, 2020
September 15, 2020 Abu-Ramaileh, Anisa
September 15, 2020
September 15, 2020 Abouzari, Moe
ACCREDITATION--
The Infectious Disease Association of California (IDAC) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. IDAC takes responsibility for the content, quality, and scientific integrity of this CME activity.

PHYSICIANS: IDAC designates this educational activity for a maximum of 6.0* AMA PRA Category 1 Credit(s)™ and American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program points for medical knowledge. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.

PHARMACISTS: The California Board of Pharmacy accepts coursework which meets the standard of relevance to pharmacy practice and has been approved for AMA PRA Category 1 Credit™. A maximum of 6.0* C.E.U.s may be reported.

NURSES: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1. Credits™. A maximum of 6.0* C.E.U.s may be reported. .



Powered by Wild Apricot Membership Software